ClinMax

Real World evidence (RWE)

Real-world-evidence-500x333

Real-World Evidence Insights

Real-world evidence (RWE) services involve the use of data collected outside of traditional clinical trials to assess the effectiveness, safety, and value of treatments in real-world settings. This data, often sourced from electronic health records, patient registries, and insurance claims, provides insights into how treatments perform in diverse patient populations. RWE helps inform healthcare decisions, guide policy, and improve patient outcomes by offering a more comprehensive understanding of treatment impact.

Real World evidence (RWE):

Clinical & Health Information Abstract & analysis

Real-world evidence companies specialize in extracting and analyzing clinical and health data, transforming it into actionable insights for RWE data studies.

Systemic Literature Review & Meta-analysis

CROs in Egypt perform systematic reviews and meta-analyses, consolidating evidence to support real-world research and informed decision-making.

Retrospective Data Abstract & Analysis

By analyzing retrospective data, real-world evidence companies provide insights into historical trends, enhancing the utility of RWE data.

Economical Data Analysis & Evaluation

Economic evaluations conducted by CROs in Egypt assess the cost-effectiveness of treatments, guiding resource allocation in healthcare.

Epidemiology & observational Research Design

Real-world evidence companies design epidemiological and observational studies to explore disease patterns and real-world treatment outcomes.

Disease, product, and patient registry studies

Comprehensive registry studies by real-world evidence companies collect RWE data to track disease progression, product efficacy, and patient experiences.

Post Authorization Safety Studies (PASS)

PASS conducted by CROs in Egypt monitor long-term drug safety, ensuring compliance with regulatory standards and enhancing patient safety.

Expanded access / Compassionate use / Managed Access Studies

Real-world evidence companies manage expanded access programs, offering treatments to patients while gathering valuable RWE data on outcomes.